Are you Dr. Stempien?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
325 Santa Ana Ave
San Francisco, CA 94127Phone+1 415-334-1427
Summary
- Dr. Mary Jean Stempien, MD is an internist in San Francisco, California.
Publications & Presentations
PubMed
- 105 citationsRandomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3).Wolfgang H. Oertel, Karla Eggert, Rajesh Pahwa, Caroline M. Tanner, Robert A. Hauser
Movement Disorders. 2017-08-21 - 114 citationsADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.Rajesh Pahwa, Caroline M. Tanner, Robert A. Hauser, Stuart Isaacson, Paul A. Nausieda
JAMA Neurology. 2017-08-01 - 40 citationsADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study.Robert A. Hauser, Rajesh Pahwa, Caroline M. Tanner, Wolfgang H. Oertel, Stuart Isaacson
Journal of Parkinson's Disease. 2017-01-01